$FBIO

Fortress Biotech Investigated by the Portnoy Law Firm - Fortress Biotech (NASDAQ:FBIO)

LOS ANGELES, Oct. 01, 2025 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Fortress Biotech Inc., ( "Slide" or the "Company" ) ( NASDAQ:FBIO ) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Original reporting
Benzinga · Globe Newswire
Published Oct 1, 2025, 7:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Oct 1, 2025, 8:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Fortress Biotech Investigated by the Portnoy Law Firm - Fortress Biotech (NASDAQ:FBIO) — source image
Decision brief

The 30-second read

$FBIOBearishMed
01

Why it matters

Legal investigations typically cause short-term stock declines; the extent depends on investigation outcomes and company responses.

02

Market read

The news has limited immediate impact but could influence investor sentiment and stock volatility.

03

What to watch

Potential for the company to strengthen governance and address concerns, which may mitigate negative impacts over time.

Timing: immediate, as news is recent and ongoing

Background

Fortress Biotech is under investigation by the Portnoy Law Firm for possible securities fraud, raising concerns among investors.

Company-level read

Ticker impact

$FBIOBearishMedium confidence
Context

The news pertains directly to Fortress Biotech (NASDAQ:FBIO), involving an investigation into potential securities fraud, which could impact investor confidence and stock performance.

Expected impact

Potential short-term decline of 5-10% due to increased uncertainty and investor concern.

Evidence & confidence

Legal investigations often cause short-term negative price movements; however, the overall impact depends on the investigation's outcome and company response.

Market effects

Possible increased scrutiny on biotech firms, leading to sector-wide cautiousness.

Limited, as the news pertains specifically to a U.S.-listed company.

Negligible, primarily affecting investor perception of the company and sector.

Counterpoint

Legal investigations can be a temporary distraction; if the company demonstrates transparency and resolves issues, stock could recover quickly.

Key entities

  • Portnoy Law Firm

    The firm conducting the investigation into Fortress Biotech.

  • Fortress Biotech

    The subject of the investigation, listed on NASDAQ.

Related articles

$AALMed

American Airlines Management Shake-up Aims To Close Leverage With Competitors and Improve Service

American Airlines began a senior leadership reorganization, according to an Aug. 10 letter from CEO Robert Isom. Several executives are resigning or retiring, while roles expand for communications and customer service. The changes aim to improve operations and returns and close a profit gap versus Delta and United. In Q2 2026, American reported $71M net income versus $805M at United and $1.6B at Delta.

$RIOMed

Federal politics live: $2.5bn Tomago bailout 'vital' to protect Australia's largest aluminium smelter, minister says

Australia’s federal and NSW governments will announce a $2.5 billion, 10-year bailout for Tomago Aluminium, aimed at securing power supply and decarbonisation. Industry Minister Tim Ayres said the deal includes profit sharing with the Commonwealth when aluminium prices are high and $100 million for decarbonisation and demand-response. Separately, Labor will introduce a revised News Bargaining Incentive bill requiring big tech to make at least eight content deals.

$LMTMedAI 8/10

Lockheed Martin wins $211 million UAE defense contract

Lockheed Martin (NYSE:LMT) said the U.S. Missile Defense Agency awarded a $211.4 million contract modification to manufacture THAAD missile defense launchers for the United Arab Emirates. The change raises the 2019 contract total to $1.05 billion, with production from Aug 2026 to Jan 2031 under Foreign Military Sales funding.

$INTCMed

5 Things to Know Before the Stock Market Opens on Tuesday

Stock futures edged higher after Monday’s decline as investors awaited AI-related earnings. Oil prices wavered after hopes for an Iran deal faded. Intel (INTC) raised its stock offering to $20B, pricing about 210.53M shares at $95. Riot Platforms (RIOT) jumped after results and a $9.1B, 20-year Anthropic compute deal. Several AI-linked earnings were scheduled.

$STEMMed

Stem, Inc.: Stem's PowerTrack EMS Enables Hybridization of Two Operating Utility-Scale Solar Plants in Hungary

Stem, Inc. (NYSE: STEM) said Solarmarkt Group, with EPC partner Pannonwatt, selected Stem’s PowerTrack Energy Management System to hybridize two operating utility-scale solar plants in Hungary. The five-year agreement covers adding 40 MW/80 MWh batteries to each site, targeting commercial operation by Sept 2026 and participation in Hungary’s aFRR market.